Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience. - Wikidata - awgldk - TriplyDB

Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.

Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.

http://www.wikidata.org/entity/Q38002454

about

Multifactorial, site-specific recurrence models after radical cystectomy for urothelial carcinoma: external validation in a cohort of Korean patients.Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer Cold Atmospheric Plasma Treatment Induces Anti-Proliferative Effects in Prostate Cancer Cells by Redox and Apoptotic Signaling Pathways.Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada.Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer.Risk groups in bladder cancer patients treated with radical cystectomy Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.Contemporary update on neoadjuvant therapy for bladder cancer.Impact of histopathological variant on the outcome of patients treated by radical cystectomy Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada.Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec.Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.Oncologic surveillance following radical cystectomy: an individualized risk-based approach.Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study

P2860

Q33769119-F2A3AEF3-576F-4219-9129-59F428B89333 Q35072460-4548447F-2EA4-4F7F-8BA9-C0806F080485 Q35680270-72FB3E98-7083-4672-9A85-A38BC5051B30 Q35736201-9958801C-72B5-42F1-8D65-A4A1EAB286DA Q36505102-74C36435-D239-437E-83D2-57C3CC9CA90A Q36575727-1B0DF083-6E26-4EE4-A4E9-28BD84ECECC8 Q37702349-0B95C1BF-B560-4599-832B-E837A67C6566 Q38843266-4BA32407-94A2-48DB-9A8F-B305DCB7A669 Q38976435-80EB4F6D-4096-44BA-99B2-73C48F292FF7 Q39177293-82CC6090-C65E-4573-9C68-754BFFAB05AE Q40906007-63B7E7A7-89DC-4A08-8085-8F3A179056CA Q41027602-A03F384D-4488-4C6E-BB6C-66AC5806CFAD Q41648995-E751344D-46A2-4807-A041-77977291AC74 Q41730736-CDB1D0D9-E7D9-4282-A70E-9060ACCD5644 Q42365275-4C23585C-E930-4DE2-9EC5-5C9B08D383D0 Q42371550-716FA668-9E01-4F70-AFA6-15B310B32688 Q48729142-B6F547DD-9F73-43BD-A5C2-326111E6B586 Q52680470-83D4FDC8-5174-4AEC-A911-B090190D7EA6 Q53160487-9D047C48-07D6-45F9-8CE5-61A43EFC724F Q55282839-51ED7EAA-4926-4163-80AC-E637784EA406 Q55334154-9A5CC630-B1BE-449E-A9F1-820B49195DC0 Q57089334-D51F105D-EB4D-4FCD-BFBC-3A7EAD380A9A

P2860

Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.

http://www.wikidata.org/entity/Q38002454

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Surveillance guidelines based ...... der Cancer Network experience.

@en

type

label

Surveillance guidelines based ...... der Cancer Network experience.

@en

prefLabel

Surveillance guidelines based ...... der Cancer Network experience.

@en

P1433

Q38002454-31863B16-FA59-44CF-9813-47FC493A747E

P1476

Q38002454-B136C3DC-C665-4282-A1BC-3926F8813AE3

P2093

Q38002454-1E76E239-51DA-430D-B8A4-542AB8819728

Q38002454-212AB11D-A22B-4F1A-8D84-82CA55B6BB93

Q38002454-26502453-1CA4-4032-BBED-45B06EBDCCF0

Q38002454-2B83F691-3270-46FF-A0D5-92C59AB8998D

Q38002454-487C7DAF-61CD-49A7-8ED7-D4A677886865

Q38002454-4E131F4A-1476-41E7-A28E-9A8D9D81AF8B

Q38002454-4EF1E8CD-D424-4E2C-A2F1-1D03293C4C12

Q38002454-5E255937-10E0-4063-BFD2-4CDC01A0606E

Q38002454-61AAFAF5-4659-492C-A494-1192C030FA9B

Q38002454-70AD5D01-4DB2-43D4-9386-C0104EA2336C

P2860

Q38002454-0147F93A-7828-4032-93B4-80262F7848D6

Q38002454-143453B2-D8EC-4DD0-B3FF-23B1A7648EBE

Q38002454-2743457F-51E8-4447-A09E-0E03F8524A87

Q38002454-2D982DF7-EDA3-4053-9604-BE399D33C125

Q38002454-5C525CC9-BE88-44B6-8405-2BA4717DA0A0

Q38002454-6CE4024C-71D7-4C06-9DE3-5D30EE5505B6

Q38002454-7BA4C42B-5E8E-4D90-A140-9D3100C68FC4

Q38002454-8411F7DF-558E-4836-A09B-E42E4EBD9CFB

Q38002454-895AE4F1-7845-40C2-93DB-AB8E83CA79D4

Q38002454-967855F9-2BBB-4889-AD8E-796757342DCE

P304

Q38002454-A64F60B9-89A0-4AC9-A980-30D450E91134

P31

Q38002454-183290AB-326D-492A-AB7D-06FE92CFF9AC

P356

Q38002454-CBBD01F8-6945-4ECE-9DC9-06405E4E34B1

P433

Q38002454-7E4AD398-46DF-4C3B-A1A2-E4345EF5ABA0

P478

Q38002454-B84DF597-DB34-410E-9FDF-0432F93111DE

P577

Q38002454-50B1470C-9462-4F77-B627-50071C85A352

P698

Q38002454-7F666D2A-1831-4743-96CB-EF725035A8F7

P356

J.1464-410X.2012.11133.X

P1433

BJU International

P1476

Surveillance guidelines based ...... der Cancer Network experience.

@en

P2093

Adrian Fairey

http://www.w3.org/2001/XMLSchema#string

Armen G Aprikian

http://www.w3.org/2001/XMLSchema#string

Darrel Drachenberg

http://www.w3.org/2001/XMLSchema#string

David Bell

http://www.w3.org/2001/XMLSchema#string

Eric Estey

http://www.w3.org/2001/XMLSchema#string

Faysal A Yafi

http://www.w3.org/2001/XMLSchema#string

Fred Saad

http://www.w3.org/2001/XMLSchema#string

Ilias Cagiannos

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Lattouf

http://www.w3.org/2001/XMLSchema#string

Jonathan Izawa

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation and follow-up strategies for superficial bladder cancer.

Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.

Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?

Cancer in Canada in 2008

The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer.

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.

A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder.

Upper tract tumours following cystectomy for bladder cancer. Is routine intravenous urography worthwhile?

High incidence of independent second malignancies after non-muscle-invasive bladder cancer.

P304

1317-1323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2012.11133.X

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22500588

http://www.w3.org/2001/XMLSchema#string